相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Highlighting Curcumin-Induced Crosstalk between Autophagy and Apoptosis as Supported by Its Specific Subcellular Localization
Francisco J. Sala de Oyanguren et al.
CELLS (2020)
Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy
Wei Guo et al.
SCIENTIFIC REPORTS (2020)
Clinical effects of curcumin in enhancing cancer therapy: A systematic review
Kamran Mansouri et al.
BMC CANCER (2020)
Curcumin, a Multifaceted Hormetic Agent, Mediates an Intricate Crosstalk between Mitochondrial Turnover, Autophagy, and Apoptosis
Nathan Earl Rainey et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
Targeting Burkitt lymphoma with a tumor cell-specific heptamethine carbocyanine-cisplatin conjugate
Stefan Mrdenovic et al.
CANCER (2019)
Ginsenoside Rb2 inhibits epithelial-mesenchymal transition of colorectal cancer cells by suppressing TGF-β/Smad signaling
Dai Guoliang et al.
PHYTOMEDICINE (2019)
Curcumin reverses oxaliplatin resistance in human colorectal cancer via regulation of TGF-beta/Smad2/3 signaling pathway
Jiahuan Yin et al.
ONCOTARGETS AND THERAPY (2019)
Knockdown of long non-coding RNA PVT1 inhibits the proliferation of Raji cells through cell cycle regulation
Chanli Zheng et al.
ONCOLOGY LETTERS (2019)
Curcumin and Its Derivatives as Potential Therapeutic Agents in Prostate, Colon and Breast Cancers
Zintle Mbese et al.
MOLECULES (2019)
Curcumin Inhibits ERK/c-Jun Expressions and Phosphorylation against Endometrial Carcinoma
Zhenxue Zhang et al.
BIOMED RESEARCH INTERNATIONAL (2019)
Curcumin in combination with anti-cancer drugs: A nanomedicine review
Harshul Batra et al.
PHARMACOLOGICAL RESEARCH (2019)
Curcumin formulated in solid lipid nanoparticles has enhanced efficacy in Hodgkin's lymphoma in mice
Jacob Guorgui et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2018)
The Problem of Curcumin and Its Bioavailability: Could Its Gastrointestinal Influence Contribute to Its Overall Health-Enhancing Effects?
Adrian L. Lopresti
ADVANCES IN NUTRITION (2018)
A combination of curcumin and oligomeric proanthocyanidins offer superior anti-tumorigenic properties in colorectal cancer
Preethi Ravindranathan et al.
SCIENTIFIC REPORTS (2018)
Homoharringtonine interacts synergistically with bortezomib in NHL cells through MCL-1 and NOXA-dependent mechanisms
Tri Nguyen et al.
BMC CANCER (2018)
Lymphoma classification update: T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms
Manli Jiang et al.
EXPERT REVIEW OF HEMATOLOGY (2017)
Homoharringtonine targets Smad3 and TGF-beta pathway to inhibit the proliferation of acute myeloid leukemia cells
Jian Chen et al.
ONCOTARGET (2017)
Targeting of BCL2 Family Proteins with ABT-199 and Homoharringtonine Reveals BCL2-and MCL1-Dependent Subgroups of Diffuse Large B-Cell Lymphoma
Magdalena Klanova et al.
CLINICAL CANCER RESEARCH (2016)
Curcumin inhibits metastasis in human papillary thyroid carcinoma BCPAP cells via down-regulation of the TGF-β/Smad2/3 signaling pathway
Li Zhang et al.
EXPERIMENTAL CELL RESEARCH (2016)
Curcumin inhibits tumor epithelial-mesenchymal transition by downregulating the Wnt signaling pathway and upregulating NKD2 expression in colon cancer cells
Zewei Zhang et al.
ONCOLOGY REPORTS (2016)
Bortezomib Inhibits Expression of TGF-β1, IL-10, and CXCR4, Resulting in Decreased Survival and Migration of Cutaneous T Cell Lymphoma Cells
Tzu-Pei Chang et al.
JOURNAL OF IMMUNOLOGY (2015)
Curcumin, Inflammation, and Chronic Diseases: How Are They Linked?
Yan He et al.
MOLECULES (2015)
The Multifaceted Role of Curcumin in Cancer Prevention and Treatment
Muthu K. Shanmugam et al.
MOLECULES (2015)
Curcumin hormesis mediates a cross-talk between autophagy and cell death
N. Rainey et al.
CELL DEATH & DISEASE (2015)
Targeting CD20+ Aggressive B-cell Non-Hodgkin Lymphoma by Anti-CD20 CAR mRNA-Modified Expanded Natural Killer Cells In Vitro and in NSG Mice
Yaya Chu et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Curcumin induces crosstalk between autophagy and apoptosis mediated by calcium release from the endoplasmic reticulum, lysosomal destabilization and mitochondrial events
A. Moustapha et al.
CELL DEATH DISCOVERY (2015)
Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: cancer and Leukemia Group B study 10002
David A. Rizzieri et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Sustained activation of SMAD3/SMAD4 by FOXM1 promotes TGF-β-dependent cancer metastasis
Jianfei Xue et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
US Food and Drug Administration Approval Summary: Omacetaxine Mepesuccinate as Treatment for Chronic Myeloid Leukemia
Firoozeh Alvandi et al.
ONCOLOGIST (2014)
Transcription factor PREP1 induces EMT and metastasis by controlling the TGF-β-SMAD3 pathway in non-small cell lung adenocarcinoma
Maurizio Risolino et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Risk factors and treatment of childhood and adolescent Burkitt lymphoma/leukaemia
Rodney R. Miles et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Transforming Growth Factor β1 (TGF-β1) Suppresses Growth of B-cell Lymphoma Cells by p14ARF-dependent Regulation of Mutant p53
Gang Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
TGF-β Signaling and the Role of Inhibitory Smads in Non-small Cell Lung Cancer
Hyo-Sung Jeon et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
A novel Raji-Burkitt's lymphoma model for preclinical and mechanistic evaluation of CD52-targeted immunotherapeutic agents
Rosa Lapalombella et al.
CLINICAL CANCER RESEARCH (2008)
分享论文
